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High altitude is defined as living at an altitude of 2400 m or
more above sea level. It is well established that prevalence of isch-
aemic heart disease is decreased in people living at high altitude
and that the mortality from this disease is lower in this cohort.
Several potential explanations have been offered for the benefit
of altitude on the frequency and outcome of ischemic heart disease.
It has been shown that hypoxia induces molecular changes that
have cardioprotective effect; this was ascribed largely to the ac-
tions of HIF-1, a transcription modulator, and up regulation of
several genes including erythropoietin, vascular endothelial
growth factor, NO synthase, and heme oxygenase-1 [1]. In our
previous studies we have shown that sub-hypoxic drop of oxy-
gen as well as mild hypoxia up-regulate SUR2A and confer
cardioprotection [2,3]. SUR2A is an “atypical” ABC protein that
binds to inward rectifier Kir6.2 to form cardiac sarcolemmal ATP-
sensitive K+ channels. In vivo, KATP channels exist as a multiprotein
complex that, besides pore-forming Kir6.1/Kir6.2 and regulatory
SUR2A subunits, also contain a string of glycolytic and ATP-
producing enzymes including creatine kinase, GAPDH and M-
LDH. It has been shown that the changes in levels of SUR2A alone
have a profound effect on hart development and myocardial
susceptibility to different types of metabolic stresses including
hypoxia, ischemia, ischemia–reperfusion and stimulation with
β-adrenergic agonists [4,5]. Depending on the degree of oxygen
decrease signaling pathway regulating SUR2A seems to be differ-
ent. In a case of sub-hypoxic drop of oxygen, the activation of extra-
cellular signal-regulated kinases (ERK) mediates up-regulation of
SUR2A [2]. On the other hand, ERK is not activated by mild hypoxia
where, instead, protein kinase B (Akt) and lactate dehydrogenase
(LDH) are activated to regulate SUR2A [3]. Whether high altitude-
hypoxia would regulate SUR2A levels and what the underlying
mechanism would be is yet unknown.
Normobaric 13% oxygen corresponds to oxygen tension at ~3600 m
above sea level. 24 h-long general exposure of mice to 13% oxygen
decreased PO2 without affecting PCO2 and hematocrit in the blood. In
themyocardial tissue, hypoxia did not affect level of lactate dehydroge-
nase (LDH), but it increased lactate as well as NAD+. NADH in the
myocardium was decreased while total NAD was not affected. Thus,
exposure to 13% oxygen induced all expected signs of hypoxia in the
blood and the heart.
It has been shown that mild hypoxia increase levels of SUR2A
and confer cardioprotection [3]. Here, 13% oxygen in vivo also
increased SUR2A in the myocardium (Fig. 1). Under physiological
levels of oxygen, fatty acids serve as the major fuel substrate pro-
viding 60–80% of the heart energy requirements, while the rest is
derived from glucose and lactate. During chronic hypoxia glucose
uptake is enhanced and there is increased contribution of glu-
cose/lactate in ATP production [6]. In vivo, it has been shown that
severe hypoxia induces significant drop in myocardial ATP, while
mild hypoxia does not affect ATP levels at all [7]. Here, we have
found that systemic exposure to 13% oxygen significantly increased
myocardial level of ATP (Fig. 1). Most of ATP produced in the heart
is catalyzed by CK [8]. Reduction in CK activity significantly reduces
myocardial levels of ATP and it induces heart failure in both
humans and experimental animals [8]. On the other hand, in-
creased level of CK is associated with increased levels of ATP [9].
Here we have measured levels of CK and found that exposure to
13% hypoxia significantly increased intracellular levels of CK
(Fig. 1). Up-regulation of CK by chronic hypoxia has been recently
reported [10] and our findings are in agreement with this report.
An increased level of CK by hypoxia explains increased ATP in the
heart we found. It has been shown in previous studies that sub-
hypoxic drop of oxygen activates extracellular regulated kinases
1/2 (ERK1/2) and that mild hypoxia activates protein kinase B
(Akt) to up-regulate SUR2A [2,3]. 13% oxygen did not have any
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effect on ERK1/2 and Akt (data not shown), demonstrating that
these kinases did not mediate observed increase in SUR2A. Akt is
known to up-regulate LDH that, in turn, directly regulate expression
of SUR2A [3]. In the present study, 13% oxygen did not significantly
affect LDH levels which further confirms that up-regulation of
SUR2A was not associated with signaling pathway activated by 18%
oxygen.
ATP is a defining ligand of KATP channels and it is well es-
tablished that this nucleotide regulates the channel activity [4].
SUR2A is a regulatory unit of KATP channels and a rate-limiting
factor in formation of these channels [4]. Gating of KATP channels
by ATP has been viewed as a link between membrane excitability
and intracellular metabolism [4]. Here, we have examined whether
a treatment known to alter intracellular ATP would have any effect
on SUR2A levels and cellular resistance to stress. Embryonic rat
heart H9c2 cells were treated by 2-deoxyglucose and this treat-
ment 1) decreased intracellular ATP, 2) decreased SUR2A levels
and 3) decreased cellular resistance to stress (Fig. 2). These results
were compatible with the notion that intracellular ATP regulates
SUR2A levels. To further test this hypothesis, we have applied
DFNB, an inhibitor of CK. When DFNB was used in a concentration
that did not affect intracellular ATP levels, SUR2A levels were also
not affected (Fig. 2). On the other hand, when DFNB was applied
in a concentration that decreased ATP, it also decreased SUR2A
levels (Fig. 2). These findings strongly suggest that intracellular
ATP regulate levels of SUR2A in the heart. Does ATP directly regu-
late SUR2A levels or whether it regulates ATP-depending factors
regulating SUR2A has to be addressed in the future.
In conclusion, this study has shown that hypoxia in vivo regulates
level of cardioprotective SUR2A by regulating intracellular ATP. This is
a previously unrecognized link between intracellular metabolism and
cardioprotection.
Conflict of interest
The authors report no relationships that could be construed as a
conflict of interest.
A
U
0
20
40
60
80
100
120 21% O2
13% O2
SUR2A
∗
n
m
o
l/l
0
10
20
30
40
21% O2
13% O2
ATP
∗
U
/L
0
200
400
600
800
1000
21% O2
13% O2
CK
∗
21%
SUR2A
13%
B
C
A
D
Fig. 1. Systemic exposure to 13% oxygen for 24 h increases SUR2A, ATP and CK in themyocardium.OriginalWestern blots for SUR2Aunder labeled conditions (A) and corresponding graph
(B) as well as bar graphs depicting ATP (C) and CK levels (D) in the myocardial tissue under the same conditions. Each bar is a mean ± SEM (n = 3–5). *P b 0.05. AU= arbitrary units.
Western blots and methods used to measure ATP and CK are described in details in refs. [2] and [3].
Fig. 2. Conditions decreasing intracellular ATP are also associated with decrease in SUR2A and cellular resistance to metabolic stress. Bar graphs depicting ATP (A, D, F) and SUR2A (B, E,
G) levels inH9c2 cells treated for 24 hwith 50mM2-deoxyglucose (A, B, C) or DNFB at concentration of 10 μM(D, E) or 20 μM(F, G) aswell as cell survival/death of these cells in response
to chemical hypoxia induced by 4 mM DNP (C). Inset in B represent original Western blots for SUR2A under labeled conditions. Each bar is a mean ± SEM (n = 3–5). *P b 0.05. AU =
arbitrary units. Western blots and methods used to measure ATP and CK are described in details in refs. [2] and [3].
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